Today: 13 June 2026
CrowdStrike stock price jumps on HSBC upgrade as CRWD heads into holiday-shortened week
15 February 2026
1 min read

CrowdStrike stock price jumps on HSBC upgrade as CRWD heads into holiday-shortened week

New York, Feb 15, 2026, 15:54 EST — The market wrapped up for the day.

CrowdStrike Holdings, Inc. shot up 4.4% on Friday to close at $429.64, outperforming the broader market. Analysts upgraded their rating on the stock, helping it wrap up the week strong.

With U.S. markets shut for Presidents Day on Monday, traders get an extra day off—no action until Tuesday’s bell. Risk assets, too, get the pause.

Software stocks are under the gun. Investors have been quick to cut back after the latest selloff, triggered by concerns that fast-moving AI progress could disrupt the subscription-heavy business models so many tech firms rely on.

HSBC upgraded CrowdStrike, moving the stock to “buy” from “hold” and setting a $446 price target. Analysts cited CrowdStrike’s scale along with its cloud-first strategy, saying the company stands to benefit as AI and machine learning gain ground in cybersecurity. Investing.com

Stephen Bersey, head of U.S. technology research at HSBC, isn’t buying into anxiety over AI supplanting enterprise software. “Market concerns that AI will replace enterprise software are misplaced,” he wrote in a February note. Proactiveinvestors UK

CrowdStrike makes its money from cloud-based cybersecurity subscriptions, but what really moves the stock is changes in recurring revenue and margins, not just landing a new contract. Investors focus heavily on annual recurring revenue (ARR)—that’s the key metric for how much subscription income CrowdStrike has locked in.

Shares bounced around on Friday, trading anywhere from $410.54 up to $432.85, according to market data. About 3.5 million shares changed hands.

With the holiday week cutting trading short, investors have more than just CrowdStrike on their radar. Fresh U.S. economic releases are stacked up: inflation and growth reports both land this week, each with the punch to sway rate outlooks and shift how Wall Street prices high-multiple tech plays. Earnings aren’t over, either—Palo Alto Networks and several other heavyweights are still set to announce results.

The setup cuts both ways. A bullish upgrade could easily fade if bond yields head higher, or if investors decide the AI disruption story still isn’t settled—prompting another retreat from software stocks.

CrowdStrike is heading into earnings, with its fourth-quarter and full-year results set to drop after the U.S. market close on Tuesday, March 3. The conference call begins at 5:00 p.m. Eastern.

Stock Market Today

  • Ascletis Pharma Stock Falls 41.6% in a Month, Valuation Mixed Amid Losses
    June 13, 2026, 12:37 AM EDT. Ascletis Pharma (SEHK:1672) shares dropped 4.4% last week and 41.6% over the past month, raising questions about its valuation. The stock trades at a price-to-book (P/B) ratio of 4.7x, above the Hong Kong Biotech sector average of 3.2x but below a peer group average of 12.5x, signaling mixed valuation metrics. The company remains unprofitable with a negative return on equity of 18.61%, making earnings-based measures less relevant. While longer-term returns remain positive, recent revenue and net income weaknesses alongside ongoing losses pose risks. Investors are advised to review underlying data carefully before deciding on Ascletis Pharma's stock prospects amid a cautious market sentiment.

Latest articles

SGH Limited Holds Back as ASX 200 Pushes Higher Before FY26 Results

SGH Limited Holds Back as ASX 200 Pushes Higher Before FY26 Results

13 June 2026
SGH closed at A$41.51, up 0.70% but underperformed the S&P/ASX 200’s 1.98% surge, as investors weighed solid cash flow and Boral margin gains against a high 36.03 P/E, mixed demand, and M&A risk; the next key catalyst is FY26 results on August 11, with analysts’ average target at A$47.64, 14.76% above Friday’s close.
NCR Voyix Rallies 10% After Investors Shift on Turnaround Bets

NCR Voyix Rallies 10% After Investors Shift on Turnaround Bets

13 June 2026
NCR Voyix soared 10.25% to $7.85, far outpacing the market, as investors focus on the company’s 2026 cash-flow and earnings targets; the next key catalyst is the Q2 2026 earnings update, with stock valuation appearing low if management delivers on margin and cash-flow goals, but risks remain with declining reported revenue and high debt.
Charles Schwab stock slips despite $27.8 billion January inflows as investors brace for Fed minutes
Previous Story

Charles Schwab stock slips despite $27.8 billion January inflows as investors brace for Fed minutes

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe
Next Story

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe

Go toTop